Cannabis Company News

Cannabis Company Q4 Financials Were Not Exciting

The Public Cannabis Company Revenue & Income Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis companies. This update is our first since late late February, and...
- March 16th, 2024 at 12:16 pm

Disappearing Cannabis Cash

You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers...
- March 15th, 2024 at 7:49 am

TerrAscend Q4 Dips From Strong Q3

TerrAscend Reports Fourth Quarter and Full Year 2023 Financial Results Full year 2023 record Net Revenue of $317.3 million, an increase of 28.0% year-over-year Full year 2023 Gross Profit...
- March 14th, 2024 at 4:31 pm

Cresco Labs Q4 Revenue Declines

  Cresco Labs Reports Fourth Quarter & Full Year 2023 Financial Results Demonstrating Significant Profitability and Cash Flow Improvements Continued execution of Year-of-the-Core strategy delivers strong gains to the...
- March 13th, 2024 at 8:01 am

Cannabist Q4 Revenue Slips Sequentially

  The Cannabist Company Reports Fourth Quarter and Full Year 2023 Results NEW YORK–(BUSINESS WIRE), 03/13/24–The Cannabist Company Holdings Inc. (NEO: CBST) (OTCQX: CBSTF) (FSE: 3LP) (“The Cannabist Company”...
- March 13th, 2024 at 7:38 am

AYR Wellness Generates Flat Revenue in Q4

AYR Wellness Reports Fourth Quarter and Full Year 2023 Results FY 2023 Revenue up 10% to $463.6 Million, Excluding Discontinued Operations FY 2023 GAAP Loss from Operations Improved to...
- March 13th, 2024 at 7:24 am

Ascend Q4 Revenue Increases 25%

AWH ANNOUNCES FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS Q4 2023 Net Revenue Increased 25% Year-over-Year to $140 million Q4 2023 Adjusted EBITDA Increased 15% Year-over-Year to $32...
- March 12th, 2024 at 7:28 am

More Selling After Good Financial Reports

You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers...
- March 8th, 2024 at 4:01 pm

Curaleaf Q4 Revenue Grows 4% Sequentially

Curaleaf Reports Fourth Quarter and Full Year Ended 2023 Results Fourth quarter 2023 revenue of $345 million, representing an increase of 4% quarter-over-quarter. Fourth quarter 2023 adjusted EBITDA(1) of...
- March 6th, 2024 at 4:15 pm

A Sign of Trouble for the MSOs

You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers...
- March 1st, 2024 at 3:57 pm

Ancillary Cannabis Stocks Stand Out in February

As we described in a previous article, the Global Cannabis Stock Index extended the bounce from November after the huge October loss, rallying 8.1% in December. That index was down 20.1% in 2023,...
- March 1st, 2024 at 5:18 am

Global Cannabis Stock Index Slips in February

Cannabis stocks, as measured by the Global Cannabis Stock Index,  exploded higher in late August on news that the Department of Health and Human Services had recommended to the DEA...
- February 29th, 2024 at 4:27 pm

Trulieve Beats Expectations in Q4

Trulieve Reports Fourth Quarter and Full Year 2023 Results Highlighting Year End Momentum and Cash Generation Fourth quarter performance delivered highest revenue and gross margin for the year Record...
- February 29th, 2024 at 6:20 am

Verano Q4 Revenue Declines 1% Sequentially

Verano Announces Fourth Quarter and Full Year 2023 Financial Results Record Revenue of $938 Million Increased 2023 Net Cash Provided by Operating Activities by 16% to $110 Million Generated...
- February 29th, 2024 at 6:02 am

GTI Posts Better-Than-Expected Q4

  CHICAGO and VANCOUVER, British Columbia, Feb. 28, 2024 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis...
- February 28th, 2024 at 4:15 pm

The MSOs Have Plunged

You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers...
- February 16th, 2024 at 4:07 pm

Organigram Q1 Revenue Declines

Organigram Reports First Quarter Fiscal 2024 Results Achieved positive cash flow from operations, solidified #2 market position in Canada among licensed producers, significantly improved margins sequentially quarter-over-quarter, and closed...
- February 13th, 2024 at 6:23 am

Canopy Growth May Go Away

You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers...
- February 9th, 2024 at 4:02 pm

Canopy Growth Burns Cash Again in Q3

Canopy Growth Reports Third Quarter Fiscal Year 2024 Financial Results; Achieves Third Quarter of Sequential Revenue Growth across Canada Cannabis Businesses and a Record Quarter for Medical Sales Canada...
- February 9th, 2024 at 7:33 am

Aurora Cannabis Expands With Australian Acquisition

Aurora Cannabis Acquires MedReleaf Australia Aurora becomes the largest global medical cannabis company operating in nationally legal markets. MedReleaf Australia holds the #2 position in medical cannabis within the...
- February 8th, 2024 at 7:08 am

The MSOs Are Quite Risky

You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers...
- February 2nd, 2024 at 4:08 pm

Soaring MSOs Lead Cannabis Stocks Higher in January

As we described in a previous article, the Global Cannabis Stock Index extended the bounce from November after the huge October loss, rallying 8.1% in December. That index was down 20.1% in 2023,...
- February 1st, 2024 at 5:58 am

Global Cannabis Stock Index Leaps in January

Cannabis stocks, as measured by the Global Cannabis Stock Index,  exploded higher in late August on news that the Department of Health and Human Services had recommended to the DEA...
- January 31st, 2024 at 4:25 pm

High Tide Q4 Sees Sales Lift 2% Sequentially

High Tide Releases Audited 2023 Financial Results Featuring Record Fourth Quarter Revenue of $127.1 Million, Record Adjusted EBITDA of $8.4 Million and Record Free Cash Flow of $5.7 Million,...
- January 29th, 2024 at 4:22 pm